Prof Julie McMullen
Honorary (Principal Fellow)
Baker Department of Cardiometabolic Health
34 Scholarly works
1 Projects
HIGHLIGHTS
2025
Journal article
Calcium-dependent regulation of physiological vs pathological cardiomyocyte hypertrophy
DOI: 10.1016/j.bbamcr.2025.1200462025
Journal article
Reduced PI3K(p110α) induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation
DOI: 10.1016/j.jshs.2025.1010232025
Conference Proceedings
PI3K(p110a) regulates atrial function independent of fibrosis and is a critical regulator of atrial enlargement in a setting of pressure overload-Implications for atrial myopathy & atrial fibrillation
DOI: 10.1093/eurheartj/ehaf784.47482025
Journal article
Collagen-targeted tracers for molecular imaging of atrial fibrosis and sensitive detection of atrial fibrillation.
DOI: 10.1038/s44325-025-00086-22025
Journal article
Generation and evaluation of a novel PI3K-targeting gene therapy in the failing mouse heart and healthy sheep heart
DOI: 10.1016/j.jmccpl.2025.1004782025
Journal article
Reduced PI3K and Anthracycline Treatment Prevents Exercise-Induced Cardiac Hypertrophy
DOI: 10.1016/j.hlc.2025.06.3842023
Research grants (other domestic)
Prospective Evaluation of Plasma Markers of PI3K Activity in the Healthy and Diseased Heart to Assess Cardiac Risk and Identify Future Treatment Strategies
RECENT SCHOLARLY WORKS
2025
Journal article
An optimized plasmalogen modulating dietary supplement provides greater protection in a male than female mouse model of dilated cardiomyopathy
DOI: 10.1016/j.jmccpl.2024.1002732025
Journal article
Cardiomyocyte-Specific FoxO1 Knockout Mice as Tools to Assess Cardiac Hypertrophy and Key Experimental Considerations Using Cre-loxP
DOI: 10.1007/978-1-0716-4217-7_72024
Journal article
Sex-specific regulation of the cardiac transcriptome by the protein phosphatase 2A regulatory subunit B55α
DOI: 10.1038/s44324-024-00033-22024
Journal article
Distinct functional and molecular profiles between physiological and pathological atrial enlargement offer potential new therapeutic opportunities for atrial fibrillation
DOI: 10.1042/CS20240178